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Background: Familial amyloid polyneuropathy (FAP) is a hereditary form of 
amyloidosis, due to deposits of a genetic variant transthyretin (TTR) produced 
by the liver. Cardiac involvement is of major prognostic value. Diphosphonate 
scintigraphy has been suggested as a diagnostic tool for TTR- related cardiac 
amyloidosis with cardiac wall thickenning. Our aim was to evaluate the 
accuracy of 99mTc- hydroxymethylene diphosphonate (99mTc- HMPD) scinti-
graphy in FAP patients with various stages of cardiac involvement.
Methods and results: We evaluated 24 patients with proven TTR- related 
amyloidosis (17 due to Val30Met mutation, 13 females, age 42±12 years). 
Cardiac involvement was evaluated by EKG, echocardiography and cardiac 
MRI, and was classi¿ ed as absent (n=3), moderate (n=8) or manifest (n=13). 
Acquisitions were performed 3h (planar and SPECT) after i.v. injection of 740 
MBq of 99mTc- HMDP. Myocardial uptake was visually semi- quantitatively 
assessed on planar images (absent, moderate, intense compared to bone 
uptake), and a quanti¿ cation was performed on tomographic slices to avoid 
bone uptake (myocardial to noise ratio) in case of uptake.
Nine patients over 24 presented a myocardial uptake: 8 intense, 1 mode-
rate, all with severe cardiac involvement. Patients with positive uptake had 
signi¿ cantly higher cardiac walls thickening, lower LVEF and higher E/E’ 
ratio. Myocardial to noise ratio ranged from 2.6 to 8.6 (mean 5.4±2), and was 
correlated to relative wall thickness (r=0.6, p=0.05). Among the 16 patients 
with negative scans, 4 presented with manifest and 8 with moderate cardiac 
amyloidosis.
Conclusion: 99mTc- HMPD scintigraphy displayed cardiac uptake in 43% 
patients with FAP, all of which occurred in patients with manifest cardiac 
amyloidosis. Cardiac amyloidosis was more serious in patients with positive 
scan. Thus, 99mTc- HMPD scintigraphy does not represent a sensitive dia-
gnostic tool in early stages of FAP but mostly a marker of severity.
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Introduction: Iatrogenic events were de¿ ned as adverse drug reactions 
or complications induced by non- drug interventions, such as cardiac devices 
or stimulation techniques. Iatrogenic complications (IC) are associated with 
prolonged hospitalization and higher in- hospital mortality. In the real world 
IC are mainly evaluated during hospital stay. The present study focused on 
admission in a coronary care unit (CCU) for an adverse effect and we aimed: 
a) to evaluate the prevalence and the characteristics of these admissions and 
the types of iatrogeny; b) and to assess the in- hospital mortality.
Methods: From April 2008 to November 2011, all the consecutive admis-
sions caused by iatrogenic events at the CCU were prospectively studied and 
classi¿ ed in 2 groups: 1) pharmacological adverse effect (antiarrythmics, anti-
coagulant, and antiplatelets), 2) non pharmacological adverse effect (pace 
maker, Automatic Implantable Cardiovertor De¿ brillator, radiofrequency, 
stent, cardiac surgery).
Results: On 6116 admissions, 254 (4%) iatrogenic causes of admissions 
were included. Most patients were male (57%) with a mean age at 72±15 
years. The iatrogenic in- hospital mortality (7.1%) was a little lower than 
general population (8.9%). The following table presents the results of the 2 
groups.
N (%) Men Age ± SD Hospital 
death rate
 Total 254 146 (57%) 72±15 18 (7%)
1 pharmacological 
adverse effect
144 (57%) 69 (48%) 75±13 7 (5%)
2 non 
pharmacological 
adverse effect
110 (43%) 77 (70%) 68±16 11 (10%)
  NS p<0.001 p<0.001 p=0.182
Conclusion: This preliminary work shows the high frequency of iatrogenic 
events induced admissions and the high rate of hospital death in particular for 
non drug interventions, which tend toward a worse prognosis. The follow up 
of this work will be necessary to better understand the causes of iatrogeny in 
order to limit this pathology.
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Background: Familial amyloid polyneuropathy (FAP) is an autosomal 
dominant neurodegenerative disease. FAP is characterized by the systemic 
deposition of transthyretin in the peripheral nervous system and the heart. 
Individuals begin to exhibit neurologic symptoms followed by heart symp-
toms between the third and seventh decades of life. Early non invasive detec-
tion of cardiac impairment is of importance for the therapeutic management.
Aim: Our aim was to assess if natriuretic peptide (NT- proBNP) could 
predict cardiac abnormalities in a wide variety of TTR patients.
Methods: 36 patients with TTR amyloidosis had clinical, biological 
(NTproBNP) and echocardiographic assessment with left ventricle systolic 
function (LV2Dstrain), LV mass indexed (LVmassind) and LV ¿ lling pressure 
(LVFP) measurement
Results: In the all cohort, the median (IQR) age, NT- proBNP, LVEF were 
respectively 59 (41- 74), 323pg/ml (58- 1960) and 60% (51- 66). TTR gene 
mutations prevalence was 50% for Val30Met, 11% for Ser77Tyr, 8% for 
Ile107Val and Val122Ile. 4 patients were asymptomatic, 6 had isolated neu-
rologic disorders and 26 had cardiac LV abnormalities (systolic dysfunction, 
hypertrophy, increase in ¿ lling pressure) with or without neurologic disorders 
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with respectively a median NT- proBNP value of : 33 (19- 50), 54 (37- 154) and 
747(253- 2840). Using received- operator curve, NTproBNP identi¿ ed signi¿ -
cantly patients with cardiac abnormalities (Area: 0.92;(0.83- 0.99), p=0.001) 
with a threshold of 82pg/ml and sensitivity of 92% and speci¿ city of 91%. 
Conclusion: In FAP, NT- proBNP is elevated in presence of cardiac abnor-
malities. This test can be useful to follow patient with FAP and decided the 
good time to start the echocardiography follow- up by cardiologist.
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Medical history: A 68- years- old man with hypertension and atrial ¿ brilla-
tion was referred to the heart failure (HF) clinic for dyspnea. He had clinical 
sign of right HF without any neurological symptoms. Echocardiography- 
Doppler showed a concentric hypertrophy of the left ventricle (LV) with an 
ejection fraction of 51%, atria enlargement, and a restrictive transmitral À ow 
pattern. Postgadolinium delayed enhancement MRI images showed a wides-
pread enhancement in the LV wall and the atria suggesting amyloidosis. 
Biological results including serum protein electrophoresis and immuno¿ xation 
were normal, along with salivary gland biopsy. A myocardial biopsy of the 
right ventricle showed diffuse amyloid deposits. Transthyretin (TTR) immu-
nostaining was strongly positive, whereas light chain immunoglobulin detec-
tion was negative. Full sequencing of the tranthyretin gene showed a new 
heterozygote pathogenic mutation TTR- Thr75Ile.
Conclusion: A TTR- Thr75Ile substitution can cause isolated hypertrophic 
cardiomyopathy. Cardiac MRI, myocardial biopsy and TTR gene analysis 
should be recommended in such cases.
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Objective: Evaluate the cardiac MRI features in patients with transthyretin 
familial amyloid polyneuropathy (TTR- FAP)
Methods: Twenty four subjects with TTR- FAP variants underwent cardiac 
MR imaging. Nineteen patients (79%) had neurological and/or cardiologic 
symptoms and the remaining 5 (21%) were asymptomatic. Eight patients 
(33%) had isolated neurological symptoms. Examinations were conducted on 
a 1.5T clinical MR system. All cases were explored with cine Steady State 
Free Precession sequences and late enhancement sequences acquired 10 after 
gadolinium injection. Volumes, ejection fraction and left ventricular mass 
were calculated on a dedicated platform.
Results: Of the 24 cases, their mean age was 55 +/- 17 years and 67% were 
men. Mean diastolic and systolic volumes were 71 +/- 12mL/m2 and 30 +/- 
11mL/m2, respectively. Mean ejection fraction and left ventricular mass were 
58 +/- 10% and 80 +/- 32 g/m2, respectively. Left ventricular mass was sta-
tistically (P<0.05) higher in the 19 symptomatic (86 +/- 30 g/m2) than in the 
5 asymptomatic cases (57 +/- 10 g/m2). Contrast enhancement abnormalities 
were found in 14 patients (58%). All these patients had involvement of the 
left ventricle (LV), with an enhancement pattern described as focal (n=10), 
diffuse (n=3) or subendocardial (n=1). Twelve of these 14 patients (86%) 
exhibited additional enhancement, located in the right ventricle (3 patients) 
or in the atria (9 patients). Sixty eight% (13/19) of symptomatic patients had 
MRI cardiac abnormalities in contrast to 20% (1/5) of asymptomatic cases. 
Contrast enhancement abnormalities were found in 50% of patients (n=4) with 
isolated neur
Conclusion: Cardiac MRI is a useful investigation to detect early cardiac 
involvement in patients with TTR- FAP, especially in patients with isolated 
neurological symptoms. Focal enhancement
0069
Identi¿ cation of suitable reference genes for gene expression studies in 
normal and pathological human heart tissues
Cristina Molina [Orateur] (1), Romain Barbet (2), Eric Jacquet (2), Istvan 
Baczkó (3), Rodolphe Fischmeister (1), Anne Garnier (1)
(1) INSERM U769 - Université Paris- Sud 11, Chatenay- Malabry, France - 
(2) ICSN, CNRS UPR2301, IMAGIF qPCR- Platform, Gif- Sur- Yvette, France 
- (3) University of Szeged, Dept Pharmacology and Pharmacotherapy, 
Szeged, Hongrie
Purpose: Quantitative real- time RT- PCR (RT- qPCR) has become the 
method of choice for mRNA quanti¿ cation, but requires an accurate norma-
lization based on the use of reference genes showing invariant expression 
across various pathological conditions. Few data exist on appropriate refe-
rence genes for human heart. Our aim was to determine a set of suitable refe-
rence genes in human atrial and ventricular tissues, from right and left cavities 
in control and various diseases.
Methods: Expression of 16 reference genes (Actb, Polr2a, Ywhaz, Pgk1, 
Ppia, Gapdh, Ipo8, Hmbs, Hprt1, Gusb, 18S, B2m, Rplp0, Tbp, Tfrc, Ubc) 
was assessed in tissue from right and left ventricle from healthy and heart 
failure (HF) patients; tissue from right atrium from patients in sinus rhythm 
(SR) with or without atrium dilatation, patients with paroxysmal atrial ¿ brilla-
tion (AF), with chronic AF or HF; and tissue from left atrium from patients in 
SR and in AF. RT- qPCR was performed using Taqman® Human Endogenous 
Control Arrays on a 7900HT system (Applied Biosystems). Expression varia-
bility of these genes was evaluated by geNorm and Norm¿ nder algorithms, 
BestKeeper software tool and comparative delta- Ct method.
Results: Preliminary consensual analysis of the variability scores obtained 
for each reference gene expression shows that the most stable genes are: Ipo8, 
Ywhaz and Polr2a when comparing either right and left ventricle or ventricle 
from healthy and HF patients; Ppia, Hprt1 and Ipo8 when comparing either 
right and left atrium or atria from all pathological groups. 18S, Tbp, Actb, Tfrc 
and B2m genes were identi¿ ed as the least stable reference genes, con¿ rming 
that they are not worth of selection for normalization in human heart samples.
Conclusions: The overall most stable reference genes across different heart 
cavities and health settings were Ppia, Polr2a, Ipo8, Ywhaz and Hprt1. This 
study could provide useful guidelines for reference gene selection in qRT- PCR 
studies in human heart.
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Background: The early cardiac involvement in SLE, although not rare, is 
mostly subclinical and thus usually escapes detection 
Objective: The purpose of this work is to comparatively assess the parame-
ters of systolic and diastolic cardiac function in patients with SLE and APS.
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Methods: Consecutive patients (n=70) who were free of cardiovascular 
symptoms were divided into two groups: (1) SLE (n=40); (2) SLE with APS 
(n=30); Pulsed, continuous, colour Doppler echocardiography, and M-mode 
and B-mode studies were performed.
Results: Patients with SLE were signi¿ cantly younger than those with APS 
(p=0.03). No signi¿ cant difference was found in disease activity between the 
two groups of patients. None of the study patients had diabetes mellitus or 
hyperlipidaemia and only a small number of patients in each group had hyper-
tension, with no signi¿ cant difference between the groups.
Left ventricular end diastolic and end systolic dimensions were signi¿ -
cantly higher in SLE as compared with patients with APS (p=0.04).  Left 
ventricular ejection fractions were within the normal range in all patients, 
with no signi¿ cant difference between the groups. The left ventricular E:A 
ratio was signi¿ cantly lower in patients with APS (group 2) as compared 
with those without APS. The left ventricular isovolumic relaxation time 
(IVRT) was signi¿ cantly more prolonged in patients group 2. The groups 
compared differed in all measures of right ventricular function. The right 
ventricular E:A ratio was signi¿ cantly lower in group 2. Raised pulmo-
nary arterial pressure (PAP>30mmHg) was observed in 8 patients with SLE. 
Structural valvular abnormalities and functional valvular abnormalities were 
detected in 10 patients and were evenly distributed among the two groups 
of patients
Conclusion: In conclusion, our data indicate that echography can detect 
subclinical cardiac dysfunction in asymptomatic patients with SLE and APS. 
Diastolic dysfunction that is, independent of valvular disease and systolic dys-
function, is a prominent feature of APS and may be related to the pathoge-
nesis of the syndrome.
